Literature DB >> 12579280

Expression of tetraspanin adaptor proteins below defined threshold values is associated with in vitro invasiveness of mammary carcinoma cells.

Georg Sauer1, Christian Kurzeder, Regina Grundmann, Rolf Kreienberg, Robert Zeillinger, Helmut Deissler.   

Abstract

Tetraspanins are transmembrane adaptor proteins involved in the regulation of various fundamental cellular processes. For a number of malignant diseases, the level of expression of members of the tetraspanin family was found to correlate with tumor cell invasiveness, ability to form metastases, and poor clinical outcome. We describe the exact quantification of mRNAs coding for the tetraspanins CD9, CD63, CD82 and CD151 expressed by mammary carcinoma-derived cell lines that were classified as invasive or non-invasive according to their ability to penetrate collagen-fibroblast gels in vitro. The mean of beta2-microglobulin-normalized expression of CD9 was about 10-fold higher than the mean calculated for CD63 and about 20-fold higher than expression of CD82 and CD151. Direct comparison of tetraspanin expression of invasive and non-invasive cell lines with the Mann-Whitney test revealed a significant correlation for CD63. Grouping of cell lines in relation to threshold values of expression resulted in significant correlations for CD63 (Fisher's exact test p=0.004) and CD151 (p=0.02) but not for CD82 (p=0.065) and CD9 (p=0.168). Expression of CD9, C63 and CD151 was found to be coupled whereas CD82 was expressed independently. This highly significant association points to common mechanisms of gene regulation for this subgroup of tetraspanins. We showed that on basis of absolute amounts of tetraspanin mRNAs, at least in vitro invasiveness is clearly predictable. Our results support the assumption that downregulation of tetraspanins in breast cancer cells is an important step of tumor progression to more malignant phenotypes and underline their important role as mediators in multimolecular membrane protein complexes regulating cell adhesion and migration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12579280

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  17 in total

Review 1.  Tetraspanins and tumor progression.

Authors:  Mekel M Richardson; Lisa K Jennings; Xin A Zhang
Journal:  Clin Exp Metastasis       Date:  2010-12-24       Impact factor: 5.150

2.  Identification of metastasis-associated breast cancer genes using a high-resolution whole genome profiling approach.

Authors:  Mohamed M Desouki; Shaoxi Liao; Huayi Huang; Jeffrey Conroy; Norma J Nowak; Lori Shepherd; Daniel P Gaile; Joseph Geradts
Journal:  J Cancer Res Clin Oncol       Date:  2010-08-03       Impact factor: 4.553

3.  Validation of genomics-based prognostic tests in malignant pleural mesothelioma.

Authors:  Gavin J Gordon; Graham N Rockwell; Paul A Godfrey; Roderick V Jensen; Jonathan N Glickman; Beow Y Yeap; William G Richards; David J Sugarbaker; Raphael Bueno
Journal:  Clin Cancer Res       Date:  2005-06-15       Impact factor: 12.531

4.  Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes breast cancer cells to ErbB2 antagonists.

Authors:  Xiuwei H Yang; Ludmila M Flores; Qinglin Li; Pengcheng Zhou; Fenghui Xu; Ian E Krop; Martin E Hemler
Journal:  Cancer Res       Date:  2010-03-02       Impact factor: 12.701

5.  The tetraspanin superfamily member NET-6 is a new tumor suppressor gene.

Authors:  Huayi Huang; Khalid Sossey-Alaoui; Sarah H Beachy; Joseph Geradts
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-08       Impact factor: 4.553

Review 6.  Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies.

Authors:  S Detchokul; E D Williams; M W Parker; A G Frauman
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

7.  Profiling of the tetraspanin CD151 web and conspiracy of CD151/integrin β1 complex in the progression of hepatocellular carcinoma.

Authors:  Ranjan Prasad Devbhandari; Guo-Ming Shi; Ai-Wu Ke; Fei-Zhen Wu; Xiao-Yong Huang; Xiao-Ying Wang; Ying-Hong Shi; Zhen-Bin Ding; Yang Xu; Zhi Dai; Jia Fan; Jian Zhou
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

8.  Application of RNA-Seq transcriptome analysis: CD151 is an Invasion/Migration target in all stages of epithelial ovarian cancer.

Authors:  Rebecca A Mosig; Li Lin; Emir Senturk; Hardik Shah; Fei Huang; Peter Schlosshauer; Samantha Cohen; Robert Fruscio; Sergio Marchini; Maurizio D'Incalci; Ravi Sachidanandam; Peter Dottino; John A Martignetti
Journal:  J Ovarian Res       Date:  2012-01-24       Impact factor: 4.234

Review 9.  Prognostic Value of CD63 Expression in Solid Tumors: A Meta-analysis of the Literature.

Authors:  Hyun Min Koh; Bo Gun Jang; Dong Chul Kim
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

10.  In silico regulatory analysis for exploring human disease progression.

Authors:  Dustin T Holloway; Mark Kon; Charles DeLisi
Journal:  Biol Direct       Date:  2008-06-18       Impact factor: 4.540

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.